AI in Biopharma Manufacturing: Are We There Yet? – Détails, épisodes et analyse

Are we there yet? Jack Prior is a bioprocess engineer who has spent his career in manufacturing science and biopharma manufacturing, using process data and process models to monitor, understand and control process variation — for yield improvement, tech transfer and troubleshooting. He began in the late 1980s at MIT looking at how to apply artificial intelligence to bioprocessing, perhaps a little too soon; forty years on, in 2026, the time for AI seems finally to have arrived. The promise has never been greater, and neither have the pitfalls and the challenges. The question this podcast asks is: are we there yet — in our data readiness, in our technology, and in our regulatory frameworks? Season 1 is an experiment. There are at least forty regulatory guidances and white papers to understand, so Jack uses AI to work through them in a narrative format, one question per episode, sized for a walk. The voices are AI characters, not Jack; the views are not his or his employer's, and none of it is regulatory advice. Each episode is fact-checked, claim by claim, against the source documents, with the results in the show notes. Researched, scripted and voiced by AI systems under Jack Prior's direction. Sam and Sarah are AI characters; nothing in the episode is Jack speaking, and none of it is a statement of his views or his employer's. Generative AI can be confidently wrong — check the sources. Corrections: jack@jackprior.ai.